Loading company…
Readout AI analyzes clinical trial data and turns results into summaries and other research outputs.
Readout AI develops software that uses AI to analyze preclinical and clinical trial data and produce insights, including table descriptions, abstracts, and posters. Founded by Michael Shleifer and others, the company is based in the US and is at seed stage. In July 2023, it raised pre-seed funding led by Meridian Street Capital, Mucker Capital, and Necessary Ventures.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in